In a report released today, Lauren Lieberman from Barclays maintained a Hold rating on Procter & Gamble (PG – Research Report), with a price target of $165.00. The company’s shares closed ...

Barclays analyst Lauren Lieberman lowered the firm’s price target on Procter & Gamble to $160 from $165 and keeps an Equal Weight rating on the shares as part of a Q1 earnings preview for the consumer ...

Procter & Gamble said U.S. and European consumers pulled back on spending in March amid economic uncertainty, prompting it to ...

Click here for access. * An analyst from Barclays persists with their Equal-Weight rating on Procter & Gamble, maintaining a target price of $165. Options are a riskier asset compared to just ...

A comprehensive examination of how financial experts perceive Procter & Gamble is derived from recent ... Buy | $185.00|$180.00 | |Lauren Lieberman |Barclays |Raises |Equal-Weight | $165.00 ...

CFO Andre Schulten noted that organic sales grew 1% in Q3 2025, with pricing contributing one point. Seven out of ten product categories held or grew organic sales. Personal health care grew high ...

Procter & Gamble (PG) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

Shares of Procter & Gamble Co. PG rose 1.29% to $167.88 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.51% to 5,287 ...

Shares of Procter & Gamble Co. PG slipped 2.15% to $160.23 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.23% to 5,062 ...

Procter & Gamble said consumers in the U.S. and Europe pulled back on spending in March amid economic uncertainty as President Donald Trump began his trade wars, prompting the company to lower its ...